{"name":"CCTU","slug":"cctu","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Standard: Aprepitant","genericName":"Standard: Aprepitant","slug":"standard-aprepitant","indication":"Chemotherapy-induced nausea and vomiting","status":"phase_3"},{"name":"Experimental drug: Aprepitant","genericName":"Experimental drug: Aprepitant","slug":"experimental-drug-aprepitant","indication":"Chemotherapy-induced nausea and vomiting (CINV) prevention in patients receiving highly emetogenic chemotherapy","status":"phase_3"},{"name":"Experimental drug: Dexamethasone","genericName":"Experimental drug: Dexamethasone","slug":"experimental-drug-dexamethasone","indication":"Other","status":"phase_3"},{"name":"Experimental drug: Ondansetron","genericName":"Experimental drug: Ondansetron","slug":"experimental-drug-ondansetron","indication":"Chemotherapy-induced nausea and vomiting (CINV)","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Standard: Dexamethasone","genericName":"Standard: Dexamethasone","slug":"standard-dexamethasone","indication":"Multiple myeloma","status":"phase_3"},{"name":"Standard: Ondansetron","genericName":"Standard: Ondansetron","slug":"standard-ondansetron","indication":"Prevention of nausea and vomiting caused by cancer chemotherapy","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Active JNJ-54175446","genericName":"Active JNJ-54175446","slug":"active-jnj-54175446","indication":"Type 2 diabetes","status":"phase_2"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Experimental drug: Olanzapine","genericName":"Experimental drug: Olanzapine","slug":"experimental-drug-olanzapine","indication":"Schizophrenia","status":"phase_3"}]}],"pipeline":[{"name":"Standard: Aprepitant","genericName":"Standard: Aprepitant","slug":"standard-aprepitant","phase":"phase_3","mechanism":"Aprepitant is a substance P/neurokinin 1 (NK1) receptor antagonist.","indications":["Chemotherapy-induced nausea and vomiting","Delayed chemotherapy-induced nausea and vomiting","Postoperative nausea and vomiting"],"catalyst":""},{"name":"Standard: Dexamethasone","genericName":"Standard: Dexamethasone","slug":"standard-dexamethasone","phase":"phase_3","mechanism":"Dexamethasone is a synthetic corticosteroid that functions as a potent anti-inflammatory agent by inhibiting the production of pro-inflammatory cytokines and mediators.","indications":["Multiple myeloma","Hematological malignancies","Neurological disorders","Respiratory diseases","Inflammatory conditions"],"catalyst":""},{"name":"Active JNJ-54175446","genericName":"Active JNJ-54175446","slug":"active-jnj-54175446","phase":"phase_2","mechanism":"JNJ-54175446 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Experimental drug: Aprepitant","genericName":"Experimental drug: Aprepitant","slug":"experimental-drug-aprepitant","phase":"phase_3","mechanism":"Aprepitant blocks neurokinin-1 (NK1) receptors in the brain to prevent nausea and vomiting.","indications":["Chemotherapy-induced nausea and vomiting (CINV) prevention in patients receiving highly emetogenic chemotherapy","Post-operative nausea and vomiting (PONV) prevention"],"catalyst":""},{"name":"Experimental drug: Dexamethasone","genericName":"Experimental drug: Dexamethasone","slug":"experimental-drug-dexamethasone","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Experimental drug: Olanzapine","genericName":"Experimental drug: Olanzapine","slug":"experimental-drug-olanzapine","phase":"phase_3","mechanism":"Olanzapine is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT2A receptors in the brain.","indications":["Schizophrenia","Bipolar I disorder (acute mania and maintenance)","Treatment-resistant depression (adjunctive use)"],"catalyst":""},{"name":"Experimental drug: Ondansetron","genericName":"Experimental drug: Ondansetron","slug":"experimental-drug-ondansetron","phase":"phase_3","mechanism":"Ondansetron blocks serotonin 5-HT3 receptors on chemoreceptor trigger zone and vagal afferent nerves to prevent nausea and vomiting.","indications":["Chemotherapy-induced nausea and vomiting (CINV)","Postoperative nausea and vomiting (PONV)","Radiation-induced nausea and vomiting"],"catalyst":""},{"name":"Standard: Ondansetron","genericName":"Standard: Ondansetron","slug":"standard-ondansetron","phase":"phase_3","mechanism":"Ondansetron works by blocking serotonin receptors in the body, which helps to reduce nausea and vomiting.","indications":["Prevention of nausea and vomiting caused by cancer chemotherapy","Prevention of nausea and vomiting caused by radiation therapy"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":8,"phaseCounts":{"phase_3":7,"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}